Choongwae to enter impotence drug market.
Published: 2006-03-09 06:57:00
Updated: 2006-03-09 06:57:00
Choongwae recently made a technical license agreement with Japanese Tanabe for the semi-exclusive development of Avanafil, a new anti-impotence drug, in Korea and some part of Asian countries under a joint clinical study participation.
Avanafil is a PDE-5 inhibitors against the enzymes of supp...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
